Wanjia Group Holdings Limited, an investment holding company, engages in the wholesale and distribution pharmaceutical business in the Mainland China and Hong Kong. The company also offers hemodialysis treatment and consultancy services. It sells its products to hospitals and healthcare institutions; and companies operating pharmaceutical retail chain stores, independent pharmacies, outpatient departments of community hospitals, healthcare service stations, and clinics. Wanjia Group Holdings Limited was founded in 2004 and is headquartered in Kowloon, Hong Kong.
Frequently asked questions
What sector does Wanjia Group Holdings Ltd (0401) operate in?
Wanjia Group Holdings Ltd belongs to the Healthcare sector and operates in the Medical Distribution industry.
What is Wanjia Group Holdings Ltd (0401) current stock price?
As of the latest data, Wanjia Group Holdings Ltd stock price is HK$0.10, with a previous close of HK$0.10. Wanjia Group Holdings Ltd gained HK$0.00 in the last trading session, representing a 2% increase.
What is Wanjia Group Holdings Ltd (0401) current market capitalization?
Wanjia Group Holdings Ltd market cap is approximately 115.12 million.
What is Wanjia Group Holdings Ltd (0401) EBITDA?
Wanjia Group Holdings Ltd EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -3.35 million.
Does Wanjia Group Holdings Ltd (0401) pay dividends?
No. Wanjia Group Holdings Ltd does not pay a dividend.
What is Wanjia Group Holdings Ltd (0401) beta (volatility) score?
Wanjia Group Holdings Ltd has a beta of 1.336, suggesting it is more volatile than the market.
